The mTOR Targets 4E-BP1/2 Restrain Tumor Growth and Promote Hypoxia Tolerance in PTEN-driven Prostate Cancer

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Molecular Cancer Research

• Publication date

  2018-02-16

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1158/1541-7786.MCR-17-0696PMID 29453322
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• From genomics to functions: preclinical mouse models for understanding oncogenic pathways in prostate cancer.

  2019cited by this paper
• Previous, Current, and Future Pharmacotherapy and Diagnosis of Prostate Cancer—A Comprehensive Review

  2019cited by this paper
• PI3K-AKT-mTOR and NFκB Pathways in Ovarian Cancer: Implications for Targeted Therapeutics

  2019cited by this paper
• mTOR Signaling in Growth, Metabolism, and Disease.

  2017cited by this paper
• mTOR Signaling in Growth, Metabolism, and Disease.

  2017cited by this paper
• Mechanistic Insights into Molecular Targeting and Combined Modality Therapy for Aggressive, Localized Prostate Cancer

  2016cited by this paper
• Anti-oncogenic potential of the eIF4E-binding proteins

  2013cited by this paper
• Two phases of disulfide bond formation have differing requirements for oxygen

  2013cited by this paper
• 4E‐BP3 regulates eIF4E‐mediated nuclear mRNA export and interacts with replication protein A2

  2012cited by this paper
• Translational control in cellular and developmental processes

  2012cited by this paper
• Hypoxia disrupts the Fanconi anemia pathway and sensitizes cells to chemotherapy through regulation of UBE2T.

  2011cited by this paper
• Deregulation of cap-dependent mRNA translation increases tumour radiosensitivity through reduction of the hypoxic fraction.

  2011cited by this paper
• New Hierarchical Phosphorylation Pathway of the Translational Repressor eIF4E-binding Protein 1 (4E-BP1) in Ischemia-Reperfusion Stress*

  2010cited by this paper
• 4E-BP1 is a key effector of the oncogenic activation of the AKT and ERK signaling pathways that integrates their function in tumors.

  2010cited by this paper
• eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression

  2010cited by this paper
• Autophagy is required during cycling hypoxia to lower production of reactive oxygen species.

  2009cited by this paper
• Regulation of translation initiation in eukaryotes: mechanisms and biological targets.

  2009cited by this paper
• p53-dependent translational control of senescence and transformation via 4E-BPs.

  2009cited by this paper
• Eukaryotic initiation factor 4E binding protein family of proteins: sentinels at a translational control checkpoint in lung tumor defense.

  2009cited by this paper
• Hypoxia signalling through mTOR and the unfolded protein response in cancer

  2008cited by this paper
• Targeting the eukaryotic translation initiation factor 4E for cancer therapy.

  2008cited by this paper
• Mutant PIK3CA-bearing colon cancer cells display increased metastasis in an orthotopic model.

  2007influential reference
• Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2.

  2007cited by this paper
• Signalling to translation: how signal transduction pathways control the protein synthetic machinery.

  2007cited by this paper
• Gene expression during acute and prolonged hypoxia is regulated by distinct mechanisms of translational control

  2006cited by this paper
• ER stress‐regulated translation increases tolerance to extreme hypoxia and promotes tumor growth

  2005cited by this paper
• A Novel mTOR-Regulated Phosphorylation Site in Elongation Factor 2 Kinase Modulates the Activity of the Kinase and Its Binding to Calmodulin

  2004cited by this paper
• Exploiting tumour hypoxia in cancer treatment

  2004cited by this paper
• eIF-4E expression and its role in malignancies and metastases

  2004cited by this paper
• Hypoxia-Mediated Down-Regulation of Bid and Bax in Tumors Occurs via Hypoxia-Inducible Factor 1-Dependent and -Independent Mechanisms and Contributes to Drug Resistance

  2004cited by this paper
• Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy

  2004cited by this paper
• Gene Fusion and Overlapping Reading Frames in the Mammalian Genes for 4E-BP3 and MASK*

  2003cited by this paper
• Pten Dose Dictates Cancer Progression in the Prostate

  2003cited by this paper
• Regulation of Protein Synthesis by Hypoxia via Activation of the Endoplasmic Reticulum Kinase PERK and Phosphorylation of the Translation Initiation Factor eIF2α

  2002cited by this paper
• Hypoxia — a key regulatory factor in tumour growth

  2002influential reference
• Hierarchical phosphorylation of the translation inhibitor 4E-BP1.

  2001cited by this paper
• The eIF4E-binding proteins 1 and 2 are negative regulators of cell growth.

  1996cited by this paper
• Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide].

  1995cited by this paper
• Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function

  1994cited by this paper
• Adenine nucleotides and inhibition of protein synthesis in isolated hepatocytes incubated under different pO2 levels.

  1993cited by this paper
• Measuring behaviour: Analysis and interpretation of data

  1993cited by this paper
• Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap

  1990cited by this paper

• High 4E-BP1 expression associates with chromosome 8 gain and CDK4/6 sensitivity in Ewing sarcoma

  2025cites this paper
• Cellular and Molecular Evidence of the Synergistic Antitumour Effects of Hydroxytyrosol and Metformin in Prostate Cancer

  2025cites this paper
• Domain-Adversarial Neural Network and Explainable AI for Reducing Tissue-of-Origin Signal in Pan-cancer Mortality Classification

  2025cites this paper
• The translational inhibitor 4EBP/Thor is required for Drosophila adaptation to hypoxia

  2025cites this paper
• The EIF4EBP1 gene encoding 4EBP1 is transcriptionally upregulated by MYC and linked to shorter survival in medulloblastoma

  2024cites this paper
• mTORC1 regulates cell survival under glucose starvation through 4EBP1/2-mediated translational reprogramming of fatty acid metabolism

  2024cites this paper
• PepMLM: Target Sequence-Conditioned Generation of Therapeutic Peptide Binders via Span Masked Language Modeling

  2023cites this paper
• SaLT&PepPr is an interface-predicting language model for designing peptide-guided protein degraders

  2023cites this paper
• Longitudinal dynamics of the tumor hypoxia response: From enzyme activity to biological phenotype

  2023cites this paper
• Eukaryotic translation initiation factor 4E binding protein 1 (EIF4EBP1) expression in glioblastoma is driven by ETS1- and MYBL2-dependent transcriptional activation

  2022cites this paper
• The role of extracellular vesicles and interleukin-8 in regulating and mediating neutrophil-dependent cancer drug resistance

  2022cites this paper
• Chloroquine prevents hypoxic accumulation of HIF-1α by inhibiting ATR kinase: implication in chloroquine-mediated chemosensitization of colon carcinoma cells under hypoxia

  2022cites this paper
• 4EBP1/2 support tumorigenicity and cell survival during energetic stress by translationally regulating fatty acid synthesis

  2022cites this paper
• A Multi-Omics Pan-Cancer Analysis of 4EBP1 in Cancer Prognosis and Cancer-Associated Fibroblasts Infiltration

  2022cites this paper
• EIF4EBP1 is transcriptionally upregulated by MYCN and associates with poor prognosis in neuroblastoma

  2021cites this paper
• Translation initiation in cancer at a glance

  2021cites this paper
• Hypoxia/HIF Modulates Immune Responses

  2021cites this paper
• Arctigenin inhibits human breast cancer cell proliferation, migratory and invasive abilities and epithelial to mesenchymal transition by targeting 4EBP1

  2021cites this paper
• Inhibition of eEF2K synergizes with glutaminase inhibitors or 4EBP1 depletion to suppress growth of triple-negative breast cancer cells

  2021cites this paper
• PacBio Iso-Seq Improves the Rainbow Trout Genome Annotation and Identifies Alternative Splicing Associated With Economically Important Phenotypes

  2021cites this paper
• Correlation of DNA methylation patterns to the phenotypic features of Tibetan elite alpinists in extreme hypoxia.

  2021cites this paper
• Cellular adaptation to hypoxia through hypoxia inducible factors and beyond

  2020cites this paper
• A p53-dependent translational program directs tissue-selective phenotypes in a model of ribosomopathies

  2020cites this paper
• Targeting ERK-Hippo Interplay in Cancer Therapy

  2020cites this paper
• PI3K-AKT-mTOR and NFκB Pathways in Ovarian Cancer: Implications for Targeted Therapeutics

  2019cites this paper
• Previous, Current, and Future Pharmacotherapy and Diagnosis of Prostate Cancer—A Comprehensive Review

  2019cites this paper
• From genomics to functions: preclinical mouse models for understanding oncogenic pathways in prostate cancer.

  2019cites this paper
• The consequences of increased 4E-BP1 in polycystic kidney disease.

  2019cites this paper
• Contrôle traductionnel des fonctions des macrophages par les répresseurs 4E-BP1 et 4E-BP2

  2018cites this paper
• Hypoxia and Selective Autophagy in Cancer Development and Therapy

  2018cites this paper
• P EP MLM: T ARGET S EQUENCE -C ONDITIONED G EN - ERATION OF P EPTIDE B INDERS VIA M ASKED L AN - GUAGE M ODELING

  year unknowncites this paper